£35.0M
The funding round was led by F-Prime Capital and Foresight Partners to support risk estimation technology and workforce expansion.
Genomics builds precision healthcare tools using large-scale genetic information to prevent common diseases and cancers.
Oxford-based Genomics develops proprietary genetic algorithms to generate population-wide health risk assessments and advance preventative healthcare.
Peter Donnelly
CEO
Gil McVean
Academic
Gerton Lunter
Academic
Chris Spencer
Academic
The funding round was led by F-Prime Capital and Foresight Partners to support risk estimation technology and workforce expansion.